XML 18 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   65,052      
Balance at beginning of period at Dec. 31, 2023 $ 718,982 $ 1,627 $ 1,078,393 $ (659) $ (360,379)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 16,856   16,856    
Issuance of common stock under equity incentive plans, net of forfeitures (in shares)   587      
Issuance of common stock under equity incentive plans, net of forfeitures 10,814 $ 14 10,800    
Repurchase of common stock (in shares)   (114)      
Repurchases of common stock (3,738) $ (3) (3,735)    
Net income (loss) 103       103
Other comprehensive income (loss) (324)     (324)  
Ending balance (in shares) at Mar. 30, 2024   65,525      
Balance at ending of period at Mar. 30, 2024 $ 742,693 $ 1,638 1,102,314 (983) (360,276)
Beginning balance (in shares) at Dec. 31, 2024 66,434 66,434      
Balance at beginning of period at Dec. 31, 2024 $ 780,940 $ 1,661 1,170,017 (612) (390,126)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 20,103   20,103    
Issuance of common stock under equity incentive plans, net of forfeitures (in shares)   417      
Issuance of common stock under equity incentive plans, net of forfeitures 10,845 $ 10 10,835    
Repurchases of common stock including excise tax (in shares)   (1,156)      
Repurchases of common stock including excise tax $ (40,202) $ (28) (40,174)    
Repurchase of common stock (in shares) (1,200)        
Repurchases of common stock $ (40,000)        
Net income (loss) (4,787)       (4,787)
Other comprehensive income (loss) $ 267     267  
Ending balance (in shares) at Mar. 29, 2025 65,695 65,695      
Balance at ending of period at Mar. 29, 2025 $ 767,166 $ 1,643 $ 1,160,781 $ (345) $ (394,913)